Chromatography sales reached nearly $8.5 billion in 2016, having rebounded from weak growth due to currency effects in the previous year. In 2017, moderate sales increases are expected to continue. We project this market segment will be fueled by the rise of clinical chromatography, as well as increased regulations in the pharmaceutical and food industries, […]
We recently conducted an in-depth survey of more than 500 scientists currently using, or planning to adopt, the remarkable technology CRISPR/Cas9. Based on user-submitted budget data and our estimate of the incidence in which CRISPR/Cas 9 is currently used in labs, we estimate the market for CRISPR/Cas9 genome editing products is $200 million. And the […]
This week we’ll be releasing the results of our survey of over 600 Scientists currently using, or planning to adopt, CRISPR/Cas9 on their research. Since the advent of molecular biology technology in the 1970s, there has been steady progress in the ability to alter, or edit, gene sequences at the genomic level. The recent development […]
The demand for hepatocytes is met by many of the major commercial suppliers [e.g., Lonza, Gibco (Life Technologies)] as well as entities with a near exclusive focus on the needs of ADME/Toxicology researchers [e.g., Xenotech, Celsis IVT, BD Gentest (Corning Life Sciences)].
December 9, 2021 12:13 pm
March 30, 2021 11:47 am
October 27, 2020 2:01 pm
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.